Pure Global AI
NCT06382259Recruiting

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes: a Randomized Controlled Crossover Trial
University of British ColumbiaClinicalTrials.govother
Verified
Study focus
Disease/Condition
Type 2 Diabetes
Drug/Device/Intervention
Movement breaks
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of British Columbia
Location
Kelowna, Canada
Timeline & enrollment
Phase
N/A
Start date
Apr 25, 2024
End date
Jul 15, 2025
Enrollment
30 participants
Primary outcome

Mean 24-h glucose concentration assessed using continuous glucose monitoring assessed using continuous glucose monitoring

Summary

To conduct a randomized crossover trial to determine the acute impact of low-intensity
 movement breaks on glycemic control in physically inactive individuals living with type 2
 diabetes using continuous glucose monitoring.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06382259
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06382259 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.